Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedNov 24, 2025

DataAggregated Company Financials

Companies11

7D-3.6%
3M16.9%
1Y73.5%
YTD77.9%

Over the last 7 days, the Pharma industry has dropped 3.6%, driven by declines from every company within the industry. This takes the industry's 12 month performance to a gain of 73%. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Mon, 01 Dec 2025	ج.م48.4b	ج.م33.6b	ج.م3.6b	16.1x	13.4x	1.4x
Wed, 29 Oct 2025	ج.م52.8b	ج.م33.0b	ج.م3.7b	17x	14.3x	1.6x
Fri, 26 Sep 2025	ج.م41.3b	ج.م33.0b	ج.م3.7b	13x	11.2x	1.3x
Sun, 24 Aug 2025	ج.م37.8b	ج.م31.1b	ج.م3.4b	10.6x	11.2x	1.2x
Tue, 22 Jul 2025	ج.م33.2b	ج.م29.4b	ج.م3.1b	10.1x	10.8x	1.1x
Thu, 19 Jun 2025	ج.م28.6b	ج.م29.4b	ج.م3.1b	7.8x	9.4x	1x
Sat, 17 May 2025	ج.م29.7b	ج.م26.9b	ج.م2.6b	8.4x	11.6x	1.1x
Mon, 14 Apr 2025	ج.م28.4b	ج.م26.2b	ج.م2.8b	7.7x	10.1x	1.1x
Wed, 12 Mar 2025	ج.م27.4b	ج.م26.2b	ج.م2.8b	7.1x	9.7x	1x
Fri, 07 Feb 2025	ج.م24.9b	ج.م23.8b	ج.م2.4b	9.1x	10.4x	1x
Sun, 05 Jan 2025	ج.م23.2b	ج.م23.7b	ج.م2.4b	8.7x	9.8x	1x
Tue, 03 Dec 2024	ج.م23.5b	ج.م23.2b	ج.م2.3b	7x	10.2x	1x
Thu, 31 Oct 2024	ج.م24.1b	ج.م22.0b	ج.م2.2b	6.8x	11.2x	1.1x
Sat, 28 Sep 2024	ج.م21.7b	ج.م22.1b	ج.م2.1b	6.7x	10.1x	1x
Mon, 26 Aug 2024	ج.م19.0b	ج.م22.1b	ج.م2.4b	5.5x	7.9x	0.9x
Wed, 24 Jul 2024	ج.م19.0b	ج.م21.3b	ج.م2.5b	5x	7.8x	0.9x
Fri, 21 Jun 2024	ج.م18.1b	ج.م20.8b	ج.م2.3b	7x	7.9x	0.9x
Sun, 19 May 2024	ج.م18.0b	ج.م20.1b	ج.م1.8b	7.8x	9.9x	0.9x
Tue, 16 Apr 2024	ج.م21.1b	ج.م19.3b	ج.م1.8b	8.4x	11.9x	1.1x
Thu, 14 Mar 2024	ج.م22.8b	ج.م18.9b	ج.م2.2b	9.5x	10.2x	1.2x
Sat, 10 Feb 2024	ج.م21.5b	ج.م18.5b	ج.م2.4b	8.8x	9x	1.2x
Mon, 08 Jan 2024	ج.م18.5b	ج.م16.0b	ج.م2.2b	7.2x	8.5x	1.2x
Wed, 06 Dec 2023	ج.م20.1b	ج.م16.5b	ج.م2.2b	10.4x	9.3x	1.2x
Fri, 03 Nov 2023	ج.م15.2b	ج.م15.4b	ج.م1.9b	6.5x	7.8x	1x
Sun, 01 Oct 2023	ج.م14.1b	ج.م15.9b	ج.م2.0b	6.9x	6.9x	0.9x
Tue, 29 Aug 2023	ج.م13.8b	ج.م15.8b	ج.م2.1b	7.2x	6.6x	0.9x
Thu, 27 Jul 2023	ج.م13.5b	ج.م15.6b	ج.م2.1b	6.9x	6.4x	0.9x
Sat, 24 Jun 2023	ج.م13.8b	ج.م16.2b	ج.م2.2b	5.4x	6.2x	0.9x
Mon, 22 May 2023	ج.م13.5b	ج.م16.2b	ج.م2.4b	4x	5.6x	0.8x
Wed, 19 Apr 2023	ج.م14.5b	ج.م16.2b	ج.م2.4b	5.2x	6x	0.9x
Fri, 17 Mar 2023	ج.م13.4b	ج.م15.7b	ج.م2.3b	5.3x	5.8x	0.9x
Sun, 12 Feb 2023	ج.م14.8b	ج.م15.6b	ج.م2.3b	5.4x	6.5x	1x
Tue, 10 Jan 2023	ج.م15.2b	ج.م15.6b	ج.م2.3b	5.5x	6.7x	1x
Thu, 08 Dec 2022	ج.م14.4b	ج.م15.6b	ج.م2.3b	4.1x	6.3x	0.9x

Price to Earnings Ratio

6.3x

Thu, 08 Dec 2022

Current Industry PE

Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 13.4x which is higher than its 3-year average PE of 8.9x.

The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.4x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have grown 17% per year over the last three years.
Revenues for these companies have grown 29% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.